Eli Lilly-partnered TRexBio will apply the IPO proceeds toward clinical development of molecules designed to activate regulatory T cells to mediate immune responses and inflammation. Meanwhile, ...

The pace of change in digital innovation has exposed the ever-widening gap between digital health and Pharma commercial teams ...

Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say ...

Earlier detection is valuable, but it creates a duty that does not end when an alert appears in the electronic health record.

Cybersecurity leaders discussed how AI-driven cybersecurity attacks pose a new level of risk for hospitals and health systems ...

The Series A round was led by Oak HC/FT, with participation from Norwest, .406 Ventures, Constellation Ventures, Y Combinator ...

The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in ...

Fraud, waste, and abuse (FWA) continue to challenge dental plans as overtreatment, miscoding and inappropriate billing ...

Trilliant Health’s report identifies six trends highlighting how misaligned incentives are contributing to rising costs, poor ...

Nobody has ever needed convincing on what to fix. What they've lacked is a way to act on it themselves, in something close to ...

AI could play a meaningful role in advancing social care. Not by replacing people, but by helping them and organizations ...

Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the ...